Corn Trading with Thursday Losses
Corn futures are showing 2 to 4 ¼ cent losses so far on Thursday. There were 88 deliveries issued against July futures overnight. The CmdtyView national average Cash Corn price is 3 3/4 cents lower at $4.00 1/4. USDA’s Export Sales report from this morning showed a total of 565,810...
Nasdaq Stocks - 2026-07-09 18:52:34Prediction markets spark insider trading concerns. Here's how Goldman and other companies are responding
CNBC reached out to 50 companies about what are their trading policies for employees on prediction markets. A handful had an answer.
CNBC US - 2026-07-09 18:52:22Crude Oil Plunges Amid Trump's Remarks On U.S.-Iran Faceoff, Profit Taking
(RTTNews) - After surging over the two previous sessions, crude oil prices have tumbled on Thursday after U.S. President Donald Trump remarked that Iran is seeking a deal with the U.S., raising expectations of an end to the ongoing standoff. In addition, investors resorted to boo
Nasdaq Commodities - 2026-07-09 18:39:53Why Salesforce is staying in the portfolio despite a harsh analyst downgrade
Jim Cramer isn't ready to give up on Salesforce after KeyBanc downgraded the stock
CNBC US - 2026-07-09 18:39:25Florida's Palm Beach airport renamed for Trump
Palm Beach International Airport is now called the Donald J. Trump International Airport, the FAA said Thursday.
CNBC World - 2026-07-09 18:27:22United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know
UTHR's strong clinical wins for Tyvaso and ralinepag, along with progress in organ manufacturing, are boosting growth prospects despite rising PAH competition.
Nasdaq Stocks - 2026-07-09 18:26:003 Cheap Medical Stocks to Buy as US-Iran Tensions Keep Markets on Edge
U.S.-Iran tensions likely to lift demand for defensive plays, with Tenet Healthcare, Elevance Health and Aveanna Healthcare standing out as cheap medical stocks.
Nasdaq Stocks - 2026-07-09 18:22:00Kalshi traders see roughly 50% odds of a rate hike in 2026 as Fed is split on policy
Wednesday's Fed minutes showed a divided outlook on where interest rates are headed this year. Traders on Kalshi see a 54% likelihood of a hike before 2027.
CNBC US - 2026-07-09 18:21:16EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth?
Exelixis' zanzalintinib faces a setback, but an FDA review, phase III trials and Cabometyx momentum keep investors focused on its growth path.
Nasdaq Stocks - 2026-07-09 18:21:00